ImmunityBio Inc (IBRX) Earnings Date & Estimates

ImmunityBio Inc IBRX: $11.27

3530 John Hopkins Ct, San Diego, California, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: immunitybio.com

ImmunityBio Inc (IBRX) Stock Earning Per Share (EPS) Forecast / Estimate


$-0.122
The average consensus EPS for IBRX is $-0.122 with a high estimate of $-0.126 and Low of $-0.118 for the period 2021-09-30 and based on 3 Institutional Analysts.

Last Quarter


Actual
Estimate
Date
$-0.21$-0.418199999999999962021-03-31


Earning Per Share (EPS) History


Actual
Estimate
Date
$-0.21$-0.418199999999999962021-03-31
$-0.3$-0.183599999999999992020-12-31
$-0.2$-0.183599999999999992020-09-30
$-0.2$-0.19382020-06-30
$-0.19$-0.173400000000000032020-03-31
$-0.16$-0.204000000000000012019-12-31
$-0.16$-0.185642019-09-30
$-0.17$-0.245312019-06-30
$-0.22$-0.23972019-03-31
$-0.22$-0.321300000000000032018-12-31
$-0.3$-0.3801542018-09-30
$-0.35$-0.385562018-06-30
$-0.35$-0.3475142018-03-31
$-0.31$-0.339662017-12-31
$-0.3$-0.3260942017-09-30
$-0.29$-0.3128342017-06-30
$-0.3$-0.37232017-03-31
$-0.29$-0.44372016-12-31
$-0.39$-0.4556342016-09-30
$-0.41$-0.589562016-06-30
$-0.38$-0.374852016-03-31
$-0.97$-0.236640000000000022015-12-31
$-0.55$-0.104042015-09-30
$-1.29$-0.1359662015-06-30

What is Earnings Per Share (EPS) and Why is it Important?

EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

Latest News About ImmunityBio Inc